DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Oettle H, Riess H, Stieler JM. et al.
Second-line oxaliplatin, folinic acid, and fluorouracil versus folinic acid and fluorouracil alone for gemcitabine-refractory pancreatic cancer: outcomes from the CONKO-003 trial.
J Clin Oncol 2014;
32: 2423-2429
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.